The medicines regulator has reversed its decision to exclude pregnant and breastfeeding women from the Sisonke Covid-19 vaccine study, clearing the way for them to be included when the national inoculation drive starts in May.

The Sisonke study aims to vaccinate 500,000 healthcare workers with Johnson & Johnson’s (J&J) vaccine. It resumed on Wednesday two weeks after it was ordered by the SA Health Products Regulatory Authority (Sahpra) that it be put on hold pending a probe into reports of rare blood clots among vaccine recipients in the US...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now